While most patients with FXS are expected to have full mutation size CGG repeat expansion in the 5′ UTR of FMR1, a negative CGG repeat expansion on targeted testing does not completely exclude the diagnosis of FXS [65,71]. Here, FMR1 is linked to fragile X syndrome.